JPRN-UMIN000006534Completed未知
Feasibility study of sentinel lymph node biopsy following neoadjuvant chemotherapy in breast cancer patients - Feasibility study of sentinel lymph node biopsy following neoadjuvant chemotherapy in breast cancer patients
Sentinel Lymph node biopsy following neoadjuvant chemotherapy0 sites240 target enrollmentStarted: October 30, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 240
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.History of undergo sentinel lymph node biopsy 2.Ipsilateral breast tumor recurrence 3.Inflammatory breast cancer 4.Bilateral breast cancer 5.Women during pregnancy or breast-feeding. 6.Disqualified by doctors
Investigators
Similar Trials
Completed
Phase 2
Feasibility study of sentinel lymph node biopsy in oral and laryngo-pharyngeal cancer patients using an indocyanine green fluorescence method and a radioisotope method.Oral and pharyngo-laryngeal cancerJPRN-UMIN000006509Aichi Cancer Center20
Completed
Not Applicable
Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for early gastric cancergastric cancerJPRN-UMIN000016963Department of Gastroenterological Surgery, Osaka University30
Recruiting
Not Applicable
Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for colon cancercolon cancerJPRN-UMIN000029159Department of Gastroenterological Surgery, Osaka University30
Recruiting
Not Applicable
Feasibility study on sentinel lymph node biopsy after neoadjuvant chemotherapy in node positive patients with breast cancerBreast cancer with pocitive axillary node treated by neoadjuvant chemotherapyJPRN-UMIN000003015Department of Breast and Endocrine Surgery, Kumamoto University50
Completed
Phase 2
Sentinel lymph node biopsy feasibility study in patients with primary cutaneous melanomaMelanomaCancerISRCTN80602070Sponsor not defined - Record supplied by Institute of Cancer Research120